More cases of rare blood clots, but regulator says benefits still outweigh risk
Published
The number of cases of rare blood clots among the millions of people in the UK who have had the Oxford/AstraZeneca vaccine has risen to 168.
Full ArticlePublished
The number of cases of rare blood clots among the millions of people in the UK who have had the Oxford/AstraZeneca vaccine has risen to 168.
Full ArticleThe benefits of taking the Oxford-AstraZeneca jab "far outweigh" any "rare incidents of risk", the vaccines minister has said, as..